SRx Health Solutions Inc. (SRXH) Q3 FY26 Earnings Call

Improving Halo operations and a debt-free balance sheet support the strategy, but EMJS returns remain hypothetical.

Q3 FY26 results, source: company transcript and SEC filings
QuarterQ3 FY26
Call date2026-08-13
Length25 minutes
EPS$-0.36
Revenue$3.4M

What changed, guidance prior to now, analyst Q&A candor and the case for and against are part of Core.

All SRXH earnings ยท Back to SRXH overview

Transcript produced by Signals.AI from the company's own earnings call audio. Not personalized investment advice.